<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated">
      <PMID Version="1">35086441</PMID>
      <DateCompleted>
        <Year>2022</Year>
        <Month>04</Month>
        <Day>20</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>04</Month>
        <Day>20</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Electronic">2242-3982</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>81</Volume>
            <Issue>1</Issue>
            <PubDate>
              <Year>2022</Year>
              <Month>Dec</Month>
            </PubDate>
          </JournalIssue>
          <Title>International journal of circumpolar health</Title>
          <ISOAbbreviation>Int J Circumpolar Health</ISOAbbreviation>
        </Journal>
        <ArticleTitle>The prevalence of atrial fibrillation in Greenland: a register-based cross-sectional study based on disease classifications and prescriptions of oral anticoagulants.</ArticleTitle>
        <Pagination>
          <StartPage>2030522</StartPage>
          <MedlinePgn>2030522</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="pii" ValidYN="Y">2030522</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.1080/22423982.2022.2030522</ELocationID>
        <Abstract>
          <AbstractText>Previous studies of the prevalence of atrial fibrillation (AF) in Greenland are based on either single-point electrocardiograms (ECGs) or patients admitted with stroke. This study estimates the prevalence of AF based on disease classifications in the electronic medical record system (EMR) and prescriptions of oral anticoagulants (OACs). Patients given a diagnose classification code for AF or atrial flutter or prescribed the vitamin K antagonist Warfarin or the direct-acting oral anticoagulant Rivaroxaban were identified in the EMR. Descriptive data and selected laboratory values were extracted, and a minimum CHA<sub>2</sub>DS<sub>2</sub>-VASc score was calculated for the 790 patients identified in the EMR (66% men). A total prevalence of AF of 1.4% was found in the general population (1.8% among men and 1.0% among women), with a significantly lower prevalence among women younger than 70 years. There was a significant increase in AF-prevalence with advancing age (p&lt;0.001) for both men and women. A minimum CHA<sub>2</sub>DS<sub>2</sub>-VASc was estimated and app. 10% of the patients may be undertreated with OACs. The prevalence of AF found in this study is higher than that found in previous studies in Greenland and comparable to the prevalence found in other Western countries, indicating that AF is common in Greenland.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Albertsen</LastName>
            <ForeName>N</ForeName>
            <Initials>N</Initials>
            <Identifier Source="ORCID">0000-0002-6774-9492</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Geriatric Medicine, Aalborg University Hospital, Aalborg, Denmark.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Clinical Medicine, University of Aalborg, Aalborg, Denmark.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Arctic Health Research Centre, Aalborg University Hospital, Aalborg, Denmark.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Riahi</LastName>
            <ForeName>S</ForeName>
            <Initials>S</Initials>
            <Identifier Source="ORCID">0000-0003-1849-9463</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Clinical Medicine, University of Aalborg, Aalborg, Denmark.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Cardiology, Aalborg University Hospital, Aalborg, Denmark.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Pedersen</LastName>
            <ForeName>M L</ForeName>
            <Initials>ML</Initials>
            <AffiliationInfo>
              <Affiliation>Steno Diabetes Centre, Nuuk, Greenland.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Greenland Centre for Health Research, University of Greenland, Nuuk, Greenland.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Skovgaard</LastName>
            <ForeName>N</ForeName>
            <Initials>N</Initials>
            <AffiliationInfo>
              <Affiliation>Greenland Centre for Health Research, University of Greenland, Nuuk, Greenland.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Andersen</LastName>
            <ForeName>S</ForeName>
            <Initials>S</Initials>
            <Identifier Source="ORCID">0000-0003-3632-5213</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Geriatric Medicine, Aalborg University Hospital, Aalborg, Denmark.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Clinical Medicine, University of Aalborg, Aalborg, Denmark.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Arctic Health Research Centre, Aalborg University Hospital, Aalborg, Denmark.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Greenland Centre for Health Research, University of Greenland, Nuuk, Greenland.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Int J Circumpolar Health</MedlineTA>
        <NlmUniqueID>9713056</NlmUniqueID>
        <ISSNLinking>1239-9736</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D000925">Anticoagulants</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000284" MajorTopicYN="N">Administration, Oral</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000925" MajorTopicYN="N">Anticoagulants</DescriptorName>
          <QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D001281" MajorTopicYN="Y">Atrial Fibrillation</DescriptorName>
          <QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
          <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006116" MajorTopicYN="N" Type="Geographic">Greenland</DescriptorName>
          <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D055656" MajorTopicYN="N">Prescriptions</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D015995" MajorTopicYN="N">Prevalence</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D020521" MajorTopicYN="Y">Stroke</DescriptorName>
          <QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
          <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="Y">Arctic</Keyword>
        <Keyword MajorTopicYN="Y">Greenland</Keyword>
        <Keyword MajorTopicYN="Y">Inuit</Keyword>
        <Keyword MajorTopicYN="Y">atrial fibrillation</Keyword>
        <Keyword MajorTopicYN="Y">atrial flutter</Keyword>
        <Keyword MajorTopicYN="Y">stroke</Keyword>
      </KeywordList>
      <CoiStatement>No potential conflict of interest was reported by the author(s).</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>1</Month>
          <Day>28</Day>
          <Hour>5</Hour>
          <Minute>33</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>1</Month>
          <Day>29</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>21</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35086441</ArticleId>
        <ArticleId IdType="pmc">PMC8803055</ArticleId>
        <ArticleId IdType="doi">10.1080/22423982.2022.2030522</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Senftleber NK, Albrechtsen A, Lauritzen L, et al. Omega-3 fatty acids and risk of cardiovascular disease in Inuit: first prospective cohort study. Atherosclerosis. 2020. 
Nov;312:28–7.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">32949835</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jørgensen ME, Bjerregaard P, Kjærgaard JJ, et al. High prevalence of markers of coronary heart disease among Greenland Inuit. Atherosclerosis. 2008. 
Feb;196(2):772–778.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17306273</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kjaergaard M, Andersen S, Holten M, et al. Low occurrence of ischemic heart disease among Inuit around 1963 suggested from ECG among 1851 East Greenland Inuit. Atherosclerosis. 2009. 
Apr;203(2):599–603.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18774134</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bjorn-Mortensen K, Lynggaard F, Pedersen ML.. 
High prevalence of atrial fibrillation among Greenlanders with ischemic stroke - atrial fibrillation found in more than 30% of cases. Int J Circumpolar Health. 2013. 
Nov
22;72(1):22628.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3838969</ArticleId>
            <ArticleId IdType="pubmed">24282782</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Romero JR, Wolf PA. Epidemiology of stroke: legacy of the Framingham Heart Study. Glob Heart. 2013. 
Mar
1;8(1):67–75.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3601756</ArticleId>
            <ArticleId IdType="pubmed">23527318</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke. 1991. 
Aug;22(8):983–988.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">1866765</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Atzema CL, Khan S, Lu H, et al. Cardiovascular disease rates, outcomes, and quality of care in Ontario Métis: a population-based cohort study. PLoS One. 2015. 
Mar
20;10(3):e0121779.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4368556</ArticleId>
            <ArticleId IdType="pubmed">25793978</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wong CX, Brooks AG, Cheng YH, et al. Atrial fibrillation in Indigenous and non-Indigenous Australians: a cross-sectional study. BMJ Open. 2014. 
Oct
24;4(10):e006242.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4212186</ArticleId>
            <ArticleId IdType="pubmed">25344486</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sanchez JM, Jolly SE, Dewland TA, et al. Incident atrial fibrillation among American Indians in California. Circulation. 2019. 
Nov
5;140(19):1605–1606.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">31630530</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ugowe FE, Jackson ILR, Thomas KL. Racial and ethnic differences in the prevalence, management, and outcomes in patients with atrial fibrillation: a systematic review. Heart Rhythm. 2018. 
Sep;15(9):1337–1345.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">29803022</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Amponsah MKD, Benjamin EJ, Magnani JW. Atrial fibrillation and race - a contemporary review. Curr Cardiovasc Risk Rep. 2013. 
Oct;7(5):336–345.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3815541</ArticleId>
            <ArticleId IdType="pubmed">24198867</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chalazan B, Mol D, Darbar FA, et al. Association of rare genetic variants and early-onset atrial fibrillation in ethnic minority individuals. JAMA Cardiol. 2021. 
Jul
1;6(7):811–819.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC8100900</ArticleId>
            <ArticleId IdType="pubmed">33950154</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Viskum C, Larsen L, Hansen CB, et al. Befolkningsundersøgelsen i Grønland 2018. Levevilkår, livsstil og helbred. [The Population Survey in Greenland 2018. Living Conditions, Life Style and Health. Danish. [cited 2021 Jul 5] Available from: Befolkningsundersøgelsen i Grønland 2018. Levevilkår, livsstil og helbred (sdu.dk).</Citation>
        </Reference>
        <Reference>
          <Citation>Bundgaard M, Jarbøl DE, Paulsen MS, et al. Prevalence of the use of antihypertensive medications in Greenland: a study of quality of care amongst patients treated with antihypertensive drugs. Int J Circumpolar Health. 2012;71(1):18834.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3417658</ArticleId>
            <ArticleId IdType="pubmed">22957317</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Statistics Greenland . Expected lifetime 2000–2020. [cited 2022 Jan 4]. Available from: https://bank.stat.gl:443/api/v1/da/Greenland/BE/BE10/BE20/BEXBBDTB.px.</Citation>
        </Reference>
        <Reference>
          <Citation>Tvermosegaard M, Rønn PF, Pedersen ML, et al. Validation of cardiovascular diagnoses in the Greenlandic Hospital discharge register for epidemiological use. Int J Circumpolar Health. 2018. 
Dec;77(1):1422668.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5795743</ArticleId>
            <ArticleId IdType="pubmed">29384037</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lip GYH, Halperin JL. Improving stroke risk stratification in atrial fibrillation. Am J Med. 2010. 
Jun;123(6):484–488.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20569748</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hart RG, Benavente O, McBride R, et al. Antithrombotic therapy to prevent stroke in patients with atrial fibrillation: a meta-analysis. Ann Intern Med. 1999. 
Oct
5;131(7):492–501.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10507957</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ruff CT, Giugliano RP, Braunwald E, et al. Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials. Lancet. 2014. 
Mar
15;383(9921):955–962.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24315724</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Senftleber NK, Overvad M, Dahl-Petersen IK, et al. Diet and physical activity in Greenland: genetic interactions and associations with obesity and diabetes. Appl Physiol Nutr Metab. 2021. 
Aug;46(8):849–855.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">34107227</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Soni A, Karna S, Fahey N, et al. Age-and-sex stratified prevalence of atrial fibrillation in Rural Western India: results of SMARTIndia, a population-based screening study. Int J Cardiol. 2019. 
Apr
1;280:84.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6378127</ArticleId>
            <ArticleId IdType="pubmed">30551905</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hindricks G, Potpara T, Dagres N, et al. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): the Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Eur Heart J. 2021. 
Feb
1;42(5):373–498.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">32860505</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Katzenellenbogen JM, Woods JA, Teng THK, et al. Atrial fibrillation in the Indigenous populations of Australia, Canada, New Zealand, and the USA: a systematic scoping review. BMC Cardiovasc Disord. 2015. 
Aug
13;15(1):87.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4535416</ArticleId>
            <ArticleId IdType="pubmed">26268309</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Santos IS, Goulart AC, Olmos RD, et al. Atrial fibrillation in low- and middle-income countries: a narrative review. Eur Heart J Suppl. 2020. 
Dec
22;22(Supplement_O):O61–O77.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7753884</ArticleId>
            <ArticleId IdType="pubmed">33380945</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lip GY, Brechin CM, Lane DA. The global burden of atrial fibrillation and stroke: a systematic review of the epidemiology of atrial fibrillation in regions outside North America and Europe. Chest. 2012. 
Dec;142(6):1489–1498.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22459778</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tsialtas D, Bolognesi MG, Assimopoulos S, et al. Clinical, electrocardiographic, and echocardiographic features in hospitalized nonagenarians (90+): comparison between the genders. Gerontology. 2019;65(5):485–494.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">31112977</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Feinberg WM, Blackshear JL, Laupacis A, et al. Prevalence, age distribution, and gender of patients with atrial fibrillation: analysis and implications. Arch Intern Med. 1995. 
Mar
13;155(5):469–473.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">7864703</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Schnabel RB, Yin X, Gona P, et al. 50 year trends in atrial fibrillation prevalence, incidence, risk factors, and mortality in the Framingham Heart Study: a cohort study. Lancet. 2015. 
Jul
11;386(9989):154–162.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4553037</ArticleId>
            <ArticleId IdType="pubmed">25960110</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ko D, Rahman F, Schnabel RB, et al. Atrial fibrillation in women: epidemiology, pathophysiology, presentation, and prognosis. Nat Rev Cardiol. 2016. 
Jun;13(6):321–332.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5579870</ArticleId>
            <ArticleId IdType="pubmed">27053455</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Arias E, Xu J. USA Life Tables, 2018. Natl Vital Stat Rep. 2020. 
Nov;69(12):1–45.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">33270553</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>OECD . Health status - Life expectancy at birth [Internet]. [cited 2022 Jan 5]. Available from:
https://data.oecd.org/healthstat/life-expectancy-at-birth.htm</Citation>
        </Reference>
        <Reference>
          <Citation>Reiss AE, Pedersen ML. Smoking among patients in the primary health care system in Nuuk, Greenland. Clin Nurs Stud. 2014;2:74.</Citation>
        </Reference>
        <Reference>
          <Citation>Magnussen C, Niiranen TJ, Ojeda FM, et al. Sex differences and similarities in atrial fibrillation epidemiology, risk factors, and mortality in community cohorts: results from the biomarcare consortium (Biomarker for cardiovascular risk assessment in Europe). Circulation. 2017. 
Oct
24;136(17):1588–1597.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5657474</ArticleId>
            <ArticleId IdType="pubmed">29038167</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Selmer C, Olesen JB, Hansen ML, et al. The spectrum of thyroid disease and risk of new onset atrial fibrillation: a large population cohort study. BMJ. 2012. 
Nov
27;345(nov27 1):e7895.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3508199</ArticleId>
            <ArticleId IdType="pubmed">23186910</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Westerman S, Wenger N. Gender differences in atrial fibrillation: a review of epidemiology, management, and outcomes. Curr Cardiol Rev. 2019;15(2):136–144.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6520576</ArticleId>
            <ArticleId IdType="pubmed">30516110</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ball J, Carrington MJ, Wood KA, et al. Women versus men with chronic atrial fibrillation: insights from the Standard versus Atrial Fibrillation spEcific managemenT studY (SAFETY). PLoS One. 2013. 
May
29;8(5):e65795.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3667075</ArticleId>
            <ArticleId IdType="pubmed">23734260</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Scheuermeyer FX, Mackay M, Christenson J, et al. There are sex differences in the demographics and risk profiles of emergency department (ED) patients with atrial fibrillation and flutter, but no apparent differences in ED management or outcomes. Acad Emerg Med. 2015. 
Sep;22(9):1067–1075.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26291513</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pedersen ML, Rolskov AR, Jacobsen JL, et al. Frequent use of primary health care service in Greenland: an opportunity for undiagnosed disease case-finding. Int J Circumpolar Health. 2012. 
Jul
24;71(1):18431.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3417523</ArticleId>
            <ArticleId IdType="pubmed">22868190</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>O’Neal WT, Alam AB, Sandesara PB, et al. Sex and racial differences in cardiovascular disease risk in patients with atrial fibrillation. PLoS One. 2019. 
Sep
4;14(9):e0222147.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6726240</ArticleId>
            <ArticleId IdType="pubmed">31483839</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rathfoot C, Edrissi C, Sanders CB, et al. Gender differences in comorbidities and risk factors in ischemic stroke patients with a history of atrial fibrillation. BMC Neurol. 2021. 
May
25;21(1):209.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC8146651</ArticleId>
            <ArticleId IdType="pubmed">34034655</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gamra H, Murin J, Chiang CE, et al. Use of antithrombotics in atrial fibrillation in Africa, Europe, Asia and South America: insights from the International RealiseAF Survey. Arch Cardiovasc Dis. 2014. 
Feb;107(2):77–87.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24556189</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
